Recombinant Ailuropoda melanoleuca Serine/threonine-protein kinase greatwall (MASTL), partial

Shipped with Ice Packs
In Stock

Description

Definition and Context

Recombinant Ailuropoda melanoleuca Serine/threonine-protein kinase greatwall (MASTL), partial, refers to a genetically engineered, truncated form of the MASTL kinase derived from the giant panda (Ailuropoda melanoleuca). MASTL is a conserved mitotic kinase that regulates cell cycle progression by phosphorylating substrates like ENSA/ARPP19, which inhibit PP2A/B55 phosphatase activity . The "partial" designation indicates that this recombinant protein lacks full-length sequences, typically retaining only functional domains critical for enzymatic activity or structural studies .

Research Applications and Challenges

Potential Uses of Recombinant Partial MASTL

  1. Kinase-Phosphatase Interaction Studies: Truncated MASTL can model interactions with PP2A/B55 and substrates like ENSA .

  2. Drug Discovery: MASTL inhibitors (e.g., GKI-1) could be tested against recombinant panda MASTL to assess cross-species efficacy.

  3. DNA Damage Response Analysis: MASTL regulates recovery from DNA damage by controlling CDK1 rephosphorylation . Partial constructs may help dissect this pathway.

Technical Limitations

  • Sequence Divergence: Giant panda MASTL may exhibit unique residues impacting substrate binding or regulation compared to human orthologs.

  • Functional Redundancy: Truncated forms might lack autoinhibitory regions, altering activity profiles .

Implications for Conservation and Disease

  • Clarify evolutionary conservation of MASTL signaling in Ursidae.

  • Aid in understanding species-specific adaptations in cell cycle control, given the giant panda’s unique metabolic traits .

Future Directions

  1. Structural Characterization: Cryo-EM or crystallography of recombinant panda MASTL to resolve NCMR architecture.

  2. Comparative Kinase Assays: Test activity against human ENSA/ARPP19 and PP2A/B55.

  3. In Vivo Functional Studies: CRISPR knock-in models to assess truncated MASTL’s impact on giant panda cell cycles.

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have special requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. All proteins ship with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag preference, please inform us.
Synonyms
MASTL; GW; GWL; PANDA_017354; Serine/threonine-protein kinase greatwall; GW; GWL; EC 2.7.11.1; Microtubule-associated serine/threonine-protein kinase-like; MAST-L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Ailuropoda melanoleuca (Giant panda)
Target Names
MASTL
Uniprot No.

Target Background

Function
Serine/threonine kinase MASTL regulates mitotic entry and maintenance by inactivating protein phosphatase 2A (PP2A) during M phase. It activates ARPP19 and ENSA, which inhibit PP2A. Inactivation of PP2A maintains high cyclin-B1-CDK1 activity. MASTL is also involved in checkpoint recovery after DNA damage.
Database Links
Protein Families
Protein kinase superfamily, AGC Ser/Thr protein kinase family
Subcellular Location
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Nucleus.

Q&A

What is MASTL and what is its fundamental role in cellular processes?

MASTL (Microtubule-associated serine/threonine kinase-like), also known as Greatwall kinase (Gwl), is a key regulator of mitosis across species. In cellular processes, MASTL functions primarily by phosphorylating α-endosulfine (ENSA) and cyclic AMP-regulated 19 kDa phosphoprotein (ARPP19). When phosphorylated, these proteins bind to and inhibit protein phosphatase 2A with B55 targeting subunit (PP2A/B55), which is the principal phosphatase that dephosphorylates substrates of CDK1 .

This inhibition pathway is critical for maintaining the phosphorylation state of mitotic proteins and ensuring proper timing and progression through mitosis. MASTL is activated during mitotic entry via CDK1-mediated phosphorylation, and its kinase activity is required for mitotic progression through this mechanism .

To study MASTL methodologically, researchers should:

  • Use immunoblotting with phospho-specific antibodies to detect activation status

  • Perform kinase activity assays with purified ENSA/ARPP19 substrates

  • Employ cell synchronization techniques to track MASTL activity throughout the cell cycle

  • Use genetic approaches (siRNA, CRISPR) to assess functional consequences of MASTL manipulation

How does the structure of MASTL distinguish it from other kinases?

MASTL possesses a unique structural feature that distinguishes it from typical kinases - a non-conserved insertion of approximately 550 amino acids within its activation loop, splitting the kinase domain into two parts . This non-conserved middle region (NCMR) is essential for substrate discrimination and regulation of kinase activity.

Methodologically, structural characterization of MASTL requires:

  • Sequence analysis to identify conserved kinase domains and the NCMR region

  • Hydrogen/deuterium exchange mass spectrometry (HDX-MS) to examine protein dynamics

  • Functional analysis of truncated constructs to determine essential regions

  • Comparison with MASTL orthologs across species to identify conserved features

Research has revealed that the C-lobe in full-length MASTL forms a stable structure, whereas the N-lobe is more dynamic. The NCMR and C-tail contain few localized regions with higher-order structure . Importantly, a cryptic C-lobe exists within the NCMR that appears to be critical for catalytic activity. Truncated versions of MASTL that retain this cryptic C-lobe can maintain catalytic activity but may have different substrate specificities .

What is currently known about the regulation of MASTL protein stability?

The regulation of MASTL protein stability involves a complex interplay of protein-protein interactions and post-translational modifications. Research has identified E6AP (encoded by the UBE3A gene) as a key ubiquitin ligase that regulates MASTL protein levels .

To methodologically investigate MASTL stability:

  • Assess protein half-life using cycloheximide chase assays with and without E6AP manipulation

  • Perform co-immunoprecipitation experiments to confirm direct interaction with regulatory proteins

  • Use ubiquitination assays to identify specific lysine residues targeted for degradation

  • Monitor protein levels under various cellular stress conditions

Studies have shown that DNA damage induces MASTL upregulation within hours post treatment with damaging agents like doxorubicin, hydroxyurea, or camptothecin . This upregulation correlates with activation of ATM/ATR signaling pathways. Conversely, E6AP depletion leads to increased MASTL protein levels without significant changes in mRNA expression, while overexpression of E6AP reduces MASTL protein levels . These findings demonstrate that MASTL stability is dynamically regulated during stress responses, which has important implications for its functions beyond basic cell cycle control.

How should researchers design expression systems for recombinant Ailuropoda melanoleuca MASTL?

For optimal expression of recombinant Ailuropoda melanoleuca MASTL, researchers should consider a systematic approach:

  • Construct Design Strategies:

    • Create multiple constructs with varying boundaries to address potential solubility issues

    • Include full-length MASTL and truncated versions that retain the cryptic C-lobe within the NCMR

    • Incorporate affinity tags (His, GST, MBP) with TEV protease cleavage sites

    • Consider codon optimization for the expression system of choice

  • Expression System Selection:

    • Bacterial systems (E. coli): Suitable for truncated constructs; use low temperature induction

    • Insect cell systems (Sf9/Hi5): Preferred for full-length protein; allows for some post-translational modifications

    • Mammalian systems (HEK293): Ideal for studies requiring native-like post-translational modifications

  • Purification Protocol:

    • Multi-step purification combining affinity chromatography with ion exchange and size exclusion

    • Include phosphatase inhibitors to preserve phosphorylation status

    • Verify protein integrity by mass spectrometry

    • Assess activity with in vitro kinase assays using ENSA/ARPP19 substrates

  • Quality Control Metrics:

    • SDS-PAGE and western blotting for purity assessment

    • Circular dichroism to confirm proper folding

    • Dynamic light scattering to assess homogeneity

    • Thermal shift assays to evaluate stability

For MASTL from Ailuropoda melanoleuca specifically, researchers should utilize the available giant panda genome sequence to design appropriate primers for gene amplification, considering the conservation of MASTL across mammalian species while accounting for potential species-specific variations.

What are the optimal methodologies for measuring MASTL kinase activity?

To accurately measure MASTL kinase activity, researchers should employ complementary approaches:

  • Direct Kinase Activity Assays:

    • Radioactive assays: Incubate MASTL with [γ-32P]ATP and purified substrates (ENSA/ARPP19)

    • Non-radioactive alternatives: Use phospho-specific antibodies or phospho-sensors

    • Mass spectrometry: Identify and quantify specific phosphorylation sites

    • Reaction conditions: 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.1 mM ATP, 1 mM DTT at 30°C

  • Functional Readouts:

    • PP2A/B55 inhibition assays: Measure phosphatase activity toward model substrates

    • Cell-free systems: Use Xenopus egg extracts supplemented with recombinant MASTL

    • Cell-based reporters: Employ fluorescent reporters of PP2A/B55 activity

  • Kinetic Analysis:

    • Substrate titration: Determine Km and Vmax values

    • ATP dependence: Assess ATP binding affinity

    • Inhibitor studies: Validate specificity using GKI-1 or other MASTL inhibitors

ParameterMeasurement TechniqueExpected RangeConsiderations
Kinase Activity32P incorporation5-50 pmol/min/μgEnsure linear range
Substrate Affinity (Km)Velocity vs. substrate concentration1-10 μM for ENSA/ARPP19Use multiple substrate concentrations
Activation StatusPhospho-specific antibodies>80% activity requires phosphorylationMonitor key regulatory sites
Inhibition (IC50)Dose-response curves0.1-1 μM for GKI-1Include positive controls

When working with recombinant Ailuropoda melanoleuca MASTL specifically, researchers should compare its enzymatic properties with well-characterized human MASTL to identify any species-specific differences in substrate preference, regulation, or inhibitor sensitivity.

How can researchers effectively assess MASTL function in DNA damage response pathways?

To investigate MASTL's role in DNA damage response (DDR) pathways, researchers should implement a multi-faceted approach:

  • Cell-Based Damage Response Systems:

    • Treat cells with specific DNA damaging agents: doxorubicin, hydroxyurea, camptothecin, or ionizing radiation

    • Monitor MASTL protein levels at multiple time points (1-24 hours post-treatment)

    • Assess phosphorylation status of MASTL using phospho-specific antibodies

    • Correlate MASTL levels with activation of ATM/ATR signaling (phospho-ATM, phospho-CHK1/2)

  • Genetic Manipulation Approaches:

    • Generate MASTL knockdown/knockout cells using siRNA or CRISPR-Cas9

    • Create rescue lines with wild-type or mutant MASTL variants

    • Employ chemical inhibition with GKI-1 at doses below mitotic disruption

    • Compare cellular responses to DNA damage with and without MASTL activity

  • Pathway Analysis Techniques:

    • Evaluate phosphorylation status of key DDR proteins (γH2AX, 53BP1, RPA)

    • Assess cell cycle checkpoint activation (G2/M arrest)

    • Measure DNA repair capacity (comet assay, repair foci resolution)

    • Determine cell survival and apoptosis rates following damage

  • Mechanistic Investigations:

    • Perform co-immunoprecipitation to identify DDR-specific MASTL interactors

    • Use phosphoproteomics to identify MASTL substrates in DDR context

    • Investigate PP2A/B55 substrate dephosphorylation kinetics during recovery

    • Assess E6AP-mediated regulation of MASTL stability following damage

Research has demonstrated that DNA damage induces MASTL upregulation, consistent with ATM/ATR signaling activation . This regulation appears to be mediated in part through the E6AP ubiquitin ligase, which controls MASTL protein stability. Understanding this pathway has implications for cancer therapy, as MASTL inhibition can enhance sensitivity to DNA-damaging agents like cisplatin .

How should researchers interpret phosphoproteomic data related to MASTL activity?

Phosphoproteomic analysis of MASTL activity requires rigorous methodological approaches for accurate interpretation:

  • Experimental Design Considerations:

    • Include appropriate controls (MASTL knockout, kinase-dead mutants, inhibitor treatment)

    • Design time-course experiments to capture dynamic changes

    • Use synchronized cell populations for cell cycle-specific analysis

    • Employ both targeted and discovery-based approaches

  • Data Processing Framework:

    • Normalize phosphopeptide abundances to protein levels to distinguish regulation by phosphorylation vs. expression

    • Apply appropriate statistical tests with multiple testing correction

    • Use clustering algorithms to identify co-regulated phosphosites

    • Perform motif analysis to identify potential direct MASTL substrates

  • Biological Interpretation Strategies:

    • Distinguish direct MASTL substrates from downstream effects

    • Classify substrates by cellular function and localization

    • Compare with known CDK1 substrates and PP2A/B55 targets

    • Integrate with protein-protein interaction networks

  • Validation Approaches:

    • Confirm key phosphosites with phospho-specific antibodies

    • Perform in vitro kinase assays with recombinant proteins

    • Generate phosphomimetic and phospho-deficient mutants

    • Assess functional consequences of site-specific mutations

What comparative analyses can reveal evolutionary insights about MASTL function?

Comparative analyses of MASTL across species provide valuable evolutionary insights through several methodological approaches:

  • Sequence-Based Analyses:

    • Perform multiple sequence alignments of MASTL from diverse species

    • Calculate evolutionary rates for different domains (N-lobe, C-lobe, NCMR)

    • Identify conserved functional motifs and species-specific variations

    • Construct phylogenetic trees to visualize evolutionary relationships

  • Structural Comparisons:

    • Map conservation patterns onto structural models

    • Identify structurally conserved regions despite sequence divergence

    • Compare the NCMR organization across species

    • Analyze the conservation of regulatory phosphorylation sites

  • Functional Conservation Assessment:

    • Compare substrate specificity across species (ENSA/ARPP19 phosphorylation)

    • Evaluate cross-species complementation in knockout systems

    • Assess conservation of protein-protein interactions

    • Compare regulatory mechanisms (activation, inhibition, localization)

SpeciesMASTL NameNCMR LengthKey Regulatory FeaturesConservation Level
HumanMASTL~550 aaCDK1 phosphorylation sitesReference
MouseMastl~545 aaSimilar to humanHigh
XenopusGreatwall~500 aaMultiple mitotic phosphorylation sitesModerate
DrosophilaGreatwall~400 aaRequired for mitosisModerate
S. cerevisiaeRim15VariableNutrient-responsive regulationLow
S. pombePpk18VariableCell size controlLow
A. melanoleucaMASTL~550 aa (predicted)Presumed similar to other mammalsHigh (presumed)

MASTL appears in different forms across species: Mastl in mammals, Greatwall in amphibians and insects, Rim15 in budding yeast, and Ppk18 in fission yeast . While the core kinase function in cell cycle regulation is conserved, the specific regulatory mechanisms and additional functions show variation. For instance, yeast orthologs also play roles in nutrient signaling . Understanding these evolutionary patterns can help identify the fundamental aspects of MASTL function versus species-specific adaptations.

How should researchers interpret changes in MASTL expression in disease contexts?

When analyzing MASTL expression changes in disease contexts, researchers should employ systematic interpretative frameworks:

  • Expression Analysis Methodology:

    • Use multiple detection methods (qRT-PCR, western blot, immunohistochemistry)

    • Compare mRNA with protein levels to identify post-transcriptional regulation

    • Assess phosphorylation status alongside total protein levels

    • Evaluate subcellular localization patterns

  • Clinical Correlation Approaches:

    • Correlate MASTL expression with disease progression and patient outcomes

    • Compare across disease subtypes and stages

    • Assess relationship with established biomarkers

    • Evaluate potential as a prognostic or predictive biomarker

  • Mechanistic Interpretation Framework:

    • Analyze entire MASTL-ENSA/ARPP19-PP2A/B55 pathway components

    • Assess correlation with cell cycle markers and chromosome stability

    • Evaluate relationship with DNA damage response efficiency

    • Consider connections to treatment resistance mechanisms

  • Therapeutic Implication Assessment:

    • Determine potential for MASTL-targeted interventions

    • Evaluate synergies with existing therapies

    • Identify patient subgroups likely to benefit from MASTL inhibition

    • Consider resistance mechanisms to MASTL-directed therapies

Research has shown that MASTL upregulation is common in multiple types of cancer, including oral squamous cell carcinoma (OSCC), and is associated with aggressive clinicopathological features . In OSCC specifically, upregulation of MASTL and ENSA/ARPP19, coupled with downregulation of PP2A/B55, correlates with cisplatin resistance and poor patient survival . MASTL inhibition with GKI-1 enhances cisplatin sensitivity in cancer cells, suggesting therapeutic potential. These findings indicate that MASTL expression changes should be interpreted in the context of the entire pathway and may have important implications for treatment selection and development of combination therapies.

How can structural biology approaches enhance our understanding of MASTL function?

Advanced structural biology methods offer powerful insights into MASTL function through several methodological approaches:

  • X-ray Crystallography and Cryo-EM Strategies:

    • Crystallize functionally relevant MASTL domains separately

    • Focus on the unique NCMR region and cryptic C-lobe

    • Capture different conformational states (active/inactive)

    • Co-crystallize with substrates, ATP analogs, or inhibitors

  • Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS) Applications:

    • Map protein dynamics across different regions

    • Identify structural changes upon activation

    • Delineate binding interfaces with interacting partners

    • Assess conformational changes induced by phosphorylation

  • Computational Structural Biology Methods:

    • Perform molecular dynamics simulations to understand flexibility

    • Use homology modeling for regions lacking experimental structures

    • Apply docking studies to predict substrate and inhibitor binding

    • Implement molecular modeling to understand the NCMR organization

  • Integrative Structural Biology Approach:

    • Combine multiple techniques (SAXS, NMR, cross-linking MS)

    • Generate comprehensive structural models

    • Correlate structural features with functional data

    • Design structure-guided mutations to test hypotheses

HDX-MS analysis has revealed that the C-lobe in full-length MASTL forms a stable structure, whereas the N-lobe is more dynamic . The NCMR and C-tail contain few localized regions with higher-order structure. This structural information helps explain how truncated versions of MASTL containing the cryptic C-lobe can maintain catalytic activity .

Understanding the structural basis for MASTL function can facilitate the design of specific inhibitors and provide insights into how disease-associated mutations affect enzyme function. For Ailuropoda melanoleuca MASTL specifically, comparative structural analysis with human MASTL could reveal species-specific adaptations that might inform evolutionary biology and potentially conservation medicine.

What are the most promising approaches for developing selective MASTL inhibitors?

Developing selective MASTL inhibitors requires integrated methodological approaches:

  • High-Throughput Screening Strategies:

    • Design activity-based assays using recombinant MASTL and fluorescent substrates

    • Implement thermal shift assays for compound binding assessment

    • Utilize fragment-based screening to identify chemical starting points

    • Develop cell-based phenotypic screens monitoring PP2A/B55 activity

  • Structure-Guided Design Methods:

    • Target unique features of MASTL, particularly the ATP-binding pocket

    • Exploit structural differences between MASTL and related kinases

    • Design allosteric inhibitors targeting NCMR-mediated regulation

    • Use molecular docking to predict binding modes and guide optimization

  • Medicinal Chemistry Optimization Framework:

    • Establish structure-activity relationships (SAR)

    • Optimize for potency, selectivity, and pharmacokinetic properties

    • Address potential resistance mechanisms

    • Balance efficacy with toxicity profile

  • Validation Approaches:

    • Test inhibitors against panels of kinases to confirm selectivity

    • Utilize MASTL knockout cells as negative controls

    • Assess on-target engagement in cells using cellular thermal shift assays

    • Verify mechanism of action through phosphoproteomic profiling

GKI-1 represents the first-in-class small molecule inhibitor of MASTL kinase and has shown promising efficacy in enhancing cisplatin sensitivity in OSCC cells . Importantly, GKI-1 exhibited anti-cancer effects at doses substantially lower than those needed to disrupt mitotic entry, suggesting a therapeutic window that exploits non-mitotic functions of MASTL .

Inhibitor PropertyTesting MethodologyDesired CharacteristicsChallenges
Potency (IC50)In vitro kinase assays<100 nMMaintaining activity in cellular context
SelectivityKinase panel screening>100-fold vs. related kinasesHighly conserved ATP-binding sites
Cell PermeabilityCellular target engagementActive at 0.1-1 μM in cellsBalancing potency with physicochemical properties
In vivo EfficacyXenograft modelsEnhanced chemosensitivityDeveloping suitable formulations

Developing selective MASTL inhibitors has significant therapeutic potential, particularly for combination therapies with DNA-damaging agents in cancers where MASTL is upregulated.

How can systems biology approaches integrate MASTL function into broader cellular networks?

Systems biology approaches offer comprehensive frameworks for understanding MASTL's role within cellular networks:

  • Network Reconstruction Methods:

    • Perform protein-protein interaction screens (Y2H, AP-MS, BioID)

    • Integrate phosphoproteomic data to map kinase-substrate relationships

    • Construct signaling pathway models incorporating MASTL, ENSA/ARPP19, and PP2A/B55

    • Identify feedback and feedforward loops in the network

  • Dynamic Modeling Approaches:

    • Develop ordinary differential equation (ODE) models of the MASTL pathway

    • Simulate cell cycle dynamics with varying MASTL activity

    • Model DNA damage response incorporating the ATM-E6AP-MASTL axis

    • Predict system behavior under perturbations

  • Multi-omics Integration Strategies:

    • Combine transcriptomic, proteomic, and phosphoproteomic data

    • Correlate MASTL activity with global cellular state changes

    • Identify emergent properties from pathway interactions

    • Map MASTL-dependent processes across cell cycle phases

  • Perturbation Biology Framework:

    • Systematically perturb network components (genetic knockdowns, inhibitors)

    • Measure global responses using high-content screening

    • Identify synthetic lethal interactions with MASTL inhibition

    • Discover context-dependent functions across cell types

Research has established several key network connections for MASTL:

  • The MASTL-ENSA/ARPP19-PP2A/B55 pathway regulates mitotic progression

  • The ATM-E6AP-MASTL axis mediates DNA damage checkpoint responses

  • MASTL modulates cisplatin resistance in cancer cells through effects on DNA damage accumulation

  • Connections exist between MASTL and nutrient sensing pathways

By integrating these pathways into comprehensive network models, researchers can generate testable hypotheses about MASTL function in normal physiology and disease states. For Ailuropoda melanoleuca MASTL specifically, comparative network analysis with human MASTL could reveal species-specific adaptations in regulatory networks.

What are the most promising areas for future MASTL research in conservation biology?

MASTL research in conservation biology, particularly for the giant panda (Ailuropoda melanoleuca), presents several promising directions:

  • Reproductive Biology Applications:

    • Investigate MASTL's role in gamete formation and early embryonic development

    • Assess MASTL expression and function in reproductive tissues

    • Explore potential implications for assisted reproductive technologies

    • Correlate MASTL variants with reproductive success in breeding programs

  • Population Genetics Approach:

    • Sequence MASTL across wild and captive panda populations

    • Identify functional polymorphisms and their distribution

    • Assess genetic diversity in regulatory regions affecting MASTL expression

    • Evaluate potential adaptive significance of MASTL variants

  • Environmental Stress Response Studies:

    • Examine how environmental factors affect MASTL function

    • Investigate MASTL's role in cellular responses to habitat-related stressors

    • Assess potential impacts of climate change on MASTL-dependent processes

    • Develop ex vivo models to study environmental influences

  • Comparative Biology Framework:

    • Compare MASTL across related species with different conservation statuses

    • Correlate MASTL function with life history traits and reproductive strategies

    • Investigate MASTL in the context of species-specific adaptations

    • Use findings to inform broader conservation strategies

What non-mitotic functions of MASTL warrant further investigation?

Beyond its established role in mitosis, several non-mitotic functions of MASTL deserve deeper investigation:

  • DNA Damage Response Pathway:

    • Further characterize the ATM-E6AP-MASTL axis in checkpoint regulation

    • Investigate MASTL's role in specific DNA repair pathways

    • Determine how MASTL affects chromatin structure after damage

    • Explore targeting MASTL to enhance chemotherapy efficacy

  • Transcriptional Regulation Mechanisms:

    • Examine potential interactions with transcription factors

    • Investigate effects on chromatin remodeling complexes

    • Assess MASTL-dependent gene expression programs

    • Explore nuclear vs. cytoplasmic functions of MASTL

  • Metabolism and Nutrient Sensing:

    • Investigate connections with nutrient deprivation responses

    • Explore potential roles in metabolic adaptation

    • Assess MASTL function in cellular energy homeostasis

    • Study potential connections with mTOR signaling

  • Cytoskeletal Regulation:

    • Examine MASTL's interaction with microtubule networks

    • Investigate roles in cell migration and invasion

    • Assess contributions to cellular mechanical properties

    • Explore functions in specialized cell types (neurons, immune cells)

Research has already revealed MASTL's involvement in DNA replication through ENSA, coordination during recovery from DNA damage, and a possible function in regulating actin and cytoskeleton . MASTL upregulation correlates with cisplatin resistance in cancer, suggesting roles beyond mitotic control . The MASTL ortholog in yeast (Rim15) responds to nutrient conditions, indicating potential metabolic functions .

These emerging non-mitotic functions may be particularly relevant for understanding MASTL's role in specialized cell types and stress responses, which could have implications for both basic science and applied research in fields like conservation biology and medicine.

How might MASTL research contribute to understanding species-specific cellular adaptations?

MASTL research offers a unique lens for examining species-specific cellular adaptations through several methodological approaches:

  • Comparative Functional Genomics:

    • Compare MASTL sequence, expression, and regulation across species

    • Identify species-specific variations in the NCMR region

    • Correlate MASTL features with species' physiological traits

    • Investigate adaptive mutations in different environmental contexts

  • Species-Specific Cell Cycle Regulation:

    • Examine differences in cell cycle control across species

    • Compare MASTL-dependent checkpoints in different organisms

    • Assess variation in PP2A/B55 regulation mechanisms

    • Relate findings to species' regenerative capabilities and lifespan

  • Environmental Adaptation Analysis:

    • Study how MASTL function varies with species' habitat and environmental challenges

    • Investigate temperature-dependent regulation across species

    • Examine MASTL's role in hibernation or torpor in relevant species

    • Explore adaptations to specific environmental stressors

  • Evolutionary Medicine Applications:

    • Identify species-specific differences in disease susceptibility related to MASTL

    • Compare MASTL's role in cancer across species with varying cancer rates

    • Investigate MASTL in longevity-associated pathways across species

    • Apply insights to develop improved models for human disease

The giant panda (Ailuropoda melanoleuca) represents an interesting case study due to its unique evolutionary history, specialized diet, and conservation challenges . By comparing MASTL function between giant pandas and closely related species, researchers could gain insights into cellular adaptations related to the panda's distinctive life history traits. These comparative studies might reveal how fundamental cell cycle regulators like MASTL have been fine-tuned through evolution to support species-specific physiological requirements.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.